blast phase Chronic myeloid leukemia

blast phase Chronic myeloid leukemia is the indication for 5 drugs in DrugBank. It is covered by 6 curated, structured indications.

Also known as: blast phase Chronic myelogenous leukemia · blast phase Chronic myelocytic leukemia · Blastic Phase Chronic Myelogenous Leukemia · Chronic Myelogenous Leukemia in Blast Crisis · Chronic Myeloid Leukemia, Blast Crisis
Classified under: Bone Marrow Diseases
Hematologic Neoplasms
Hemic and Lymphatic Disease, Unclassified
Indicated drugs: Bosutinib
Cytarabine
Dasatinib
Imatinib
Ponatinib

Resolves to

Vocabularies

SNOMED CT278180008MedDRA10053747UMLSC0005699

What you can answer from here — as of October 25, 2026

5Indicated drugsWith each drug's targets and mechanism

Listed above

6Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

65Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for blast phase Chronic myeloid leukemia share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.